With @,@ patients enrolled onto the trial , a median follow-up period of @ years , and @ RFS events , we achieved an HR of @ ( one sided @ % UCB , @ ; favoring AC does not allow a conclusion of noninferiority of T with AC ; UCB > @ ) .